Saturday 17 October 2026
Export HTFL’s income statement to Excel — free account
Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024. In the quarter to June 2026, revenue grew 47.6%, EPS grew 87.7% and free cash flow grew 62.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
48.29
2.62
−5.15%
Follow HTFL
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | — | 25.38 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | — | 41.22 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | 699 | 843 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | 0.00 | 0.18 | 0.21 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 87 | 126 | 176 | ||||
| Gross margin, % | — | — | — | — | — | — | — | 66.59 | 75.07 | 76.80 | |||||
| EBT | — | — | — | — | — | — | — | (95) | (96) | (117) | |||||
| EBT margin, % | — | — | — | — | — | — | — | (109.10) | (76.60) | (66.39) | |||||
| Net income | — | — | — | — | — | — | — | (96) | (96) | (117) | |||||
| Depreciation | — | — | — | — | — | — | — | 10 | 10 | 12 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | 17.84 | 23.46 | 4.78 | ||||
| Earnings | — | — | — | — | — | — | — | (19.58) | (17.98) | (3.17) | |||||
| Cash flow | — | — | — | — | — | — | — | (15.65) | (12.87) | (1.47) | |||||
| Capex | — | — | — | — | — | — | — | (1.25) | (0.81) | (0.14) | |||||
| Free cash flow | — | — | — | — | — | — | — | (16.90) | (13.68) | (1.60) | |||||
| Book value | — | — | — | — | — | — | — | (1.84) | (16.95) | 8.16 | |||||
| Shares, m | — | — | — | — | — | — | — | 5 | 5 | 37 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | 1.28 | 1.28 | 6.10 | |||||
| P/B | — | — | — | — | — | — | — | 0.00 | 0.00 | 3.57 | |||||
| EV/Sales | — | — | — | — | — | — | — | 1.96 | 1.96 | 6.13 | |||||
| EV/FCF | — | — | — | — | — | — | — | (4.29) | (4.29) | (18.29) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | (76) | (69) | (54) | ||||
| Capex | — | — | — | — | — | — | — | (6) | (4) | (5) | |||||
| Free cash flow | — | — | — | — | — | — | — | (83) | (73) | (59) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | 116 | 49 | 178 | ||||
| Total debt | — | — | — | — | — | — | — | 134 | 136 | — | |||||
| Net debt | — | — | — | — | — | — | — | 11 | 85 | (177) | |||||
| Shareholders’ equity | — | — | — | — | — | — | — | (9) | (91) | 301 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | 0.00 | (63.49) | (48.85) | ||||
| ROIC | — | — | — | — | — | — | — | (2,031.71) | 0.00 | (32.33) | |||||
| ROE | — | — | — | — | — | — | — | 0.00 | 11.78 | 41.80 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Heartflow, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | $9.4B | — (loss-making) | — (loss-making) | −12.65% (below 0%: shrinking) | n/m | −4.61% (below 0%: shrinking) | 74.48% | (12.95%) | Compare |
| HNGE Hinge Health Inc. | $8.5B | 73.5× | 39.4× | +53.00% (above 0%: growing) | n/m | +441.14% (above 0%: growing) | 86.44% | 19.00% | Compare |
| HQY HealthEquity, Inc. | $7.7B | 33.0× | 30.2× | +7.64% (above 0%: growing) | +14.49% (above 0%: growing) | −3.44% (below 0%: shrinking) | 73.55% | 28.14% | Compare |
| DOCS Doximity, Inc. | $5.6B | 34.8× | 26.2× | +7.34% (above 0%: growing) | −53.57% (below 0%: shrinking) | −34.14% (below 0%: shrinking) | 84.87% | 21.48% | Compare |
| WAY Waystar Holding Corp. | $5.4B | 38.0× | 22.4× | +18.11% (above 0%: growing) | +10.53% (above 0%: growing) | −52.42% (below 0%: shrinking) | 69.44% | 23.79% | Compare |
| HTFL Heartflow, Inc. | $4.4B | — (loss-making) | — (loss-making) | +47.57% (above 0%: growing) | n/m | +62.62% (above 0%: growing) | 83.00% | (27.93%) | |
| PRVA Privia Health Group, Inc. | $2.9B | 102× | 87.8× | +21.39% (above 0%: growing) | +250.00% (above 0%: growing) | −86.20% (below 0%: shrinking) | 9.93% | 1.86% | Compare |
| SDGR Schrodinger, Inc. | $1.9B | — (loss-making) | — (loss-making) | +7.54% (above 0%: growing) | n/m | +34.43% (above 0%: growing) | 55.07% | (70.55%) | Compare |
| OMCL Omnicell, Inc. | $1.6B | 41.6× | 55.1× | +7.45% (above 0%: growing) | +341.67% (above 0%: growing) | +107.90% (above 0%: growing) | 48.98% | 10.39% | Compare |
| Median of peers | $5.5B | 39.8× | 34.8× | +7.59% | +14.49% | −4.02% | 71.50% | 14.70% |
Heartflow, Inc. (HTFL) key facts
- Strength: Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Heartflow, Inc. (HTFL) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, HTFL traded at $48.29, a market capitalization of $4.4 billion.
- Return on equity was 41.8% and debt-to-equity 0.00.
- Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 7.22 (safe zone) for fiscal 2025.